Aspen Aerogels, Inc. $ASPN Shares Purchased by SG Americas Securities LLC

SG Americas Securities LLC boosted its holdings in Aspen Aerogels, Inc. (NYSE:ASPN) by 98.6% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 133,821 shares of the construction company’s stock after purchasing an additional 66,427 shares during the quarter. SG Americas Securities LLC’s holdings in Aspen Aerogels were worth $792,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of ASPN. Gagnon Securities LLC purchased a new position in shares of Aspen Aerogels in the 2nd quarter valued at $11,243,000. Y Intercept Hong Kong Ltd purchased a new stake in Aspen Aerogels during the 2nd quarter worth $484,000. Nuveen LLC purchased a new stake in Aspen Aerogels during the 1st quarter worth $1,083,000. IFP Advisors Inc increased its holdings in Aspen Aerogels by 28.9% in the 1st quarter. IFP Advisors Inc now owns 26,716 shares of the construction company’s stock valued at $171,000 after purchasing an additional 5,997 shares in the last quarter. Finally, Envestnet Asset Management Inc. raised its position in Aspen Aerogels by 17.5% in the first quarter. Envestnet Asset Management Inc. now owns 55,511 shares of the construction company’s stock valued at $355,000 after purchasing an additional 8,249 shares during the period. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on ASPN. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Aspen Aerogels in a research report on Tuesday, November 18th. Canaccord Genuity Group reduced their price target on Aspen Aerogels from $10.00 to $5.00 and set a “buy” rating on the stock in a research report on Friday, November 7th. Barclays reduced their price target on Aspen Aerogels from $6.00 to $4.00 and set an “underweight” rating on the stock in a research report on Friday, November 7th. Finally, Zacks Research downgraded shares of Aspen Aerogels from a “hold” rating to a “strong sell” rating in a research report on Monday, November 10th. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, two have assigned a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, Aspen Aerogels has an average rating of “Hold” and an average target price of $12.67.

Insider Buying and Selling at Aspen Aerogels

In other news, CEO Donald R. Young sold 56,845 shares of the company’s stock in a transaction dated Thursday, November 13th. The shares were sold at an average price of $3.23, for a total value of $183,609.35. Following the sale, the chief executive officer owned 494,011 shares in the company, valued at approximately $1,595,655.53. This represents a 10.32% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 4.30% of the company’s stock.

Aspen Aerogels Stock Performance

Shares of ASPN opened at $3.12 on Monday. The firm has a market cap of $257.86 million, a price-to-earnings ratio of -0.82 and a beta of 2.85. The company has a quick ratio of 3.31, a current ratio of 3.98 and a debt-to-equity ratio of 0.34. The business’s 50 day moving average is $6.62 and its two-hundred day moving average is $6.62. Aspen Aerogels, Inc. has a 52-week low of $2.92 and a 52-week high of $15.38.

Aspen Aerogels (NYSE:ASPN) last issued its quarterly earnings results on Thursday, November 6th. The construction company reported ($0.06) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.05). The company had revenue of $73.02 million during the quarter, compared to the consensus estimate of $73.42 million. Aspen Aerogels had a positive return on equity of 2.92% and a negative net margin of 78.53%.The firm’s quarterly revenue was down 37.8% on a year-over-year basis. During the same quarter last year, the firm posted ($0.17) EPS. Aspen Aerogels has set its FY 2025 guidance at -4.150–4.050 EPS. Analysts forecast that Aspen Aerogels, Inc. will post 0.17 EPS for the current fiscal year.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.